Ligutom, Blenda .

HRN: 28-29-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2025
AMPICILLIN 1GM (VIAL)
12/19/2025
12/25/2025
IV
1.5gm
Q6hr
PROM X 5 Hours
Waiting Final Action 
12/19/2025
CEFTRIAXONE 1G (VIAL)
12/19/2025
12/19/2025
IV
2g
PTOR
Stat Cs
Checking Initial Appropriateness 
12/19/2025
CEFAZOLIN 1GM (VIAL)
12/19/2025
12/21/2025
IV
1 G
Every 8 Hours
S/P Primary CS
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: